Nitric oxide in blood: The nitrosative-oxidative disequilibrium hypothesis on the pathogenesis of cardiovascular disease

FEBS Journal

Volumn 274, Issue 4, 2007, Pages 906-923

  Elahi, Maqsood M ^a   Naseem, Khalid M ^b   Matata, Bashir M ^a  

^a LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Cardiac E C coupling; Cardiac hypertrophy; Hemoglobin oxidase; NO signaling; Oxidases; Programmed cell death; S nitrosylation; Transduction pathways

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; OXYGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOL DERIVATIVE; TRANSCRIPTION FACTOR;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ELECTRON TRANSPORT; ENDOTHELIUM; ENERGY BALANCE; ENZYME ACTIVITY; ERYTHROCYTE; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE; HOMEOSTASIS; HUMAN; MITOCHONDRION; MOLECULAR INTERACTION; NITROSATION; NITROSATIVE STRESS; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; MODELS, BIOLOGICAL; NITRATES; NITRIC OXIDE; NITRIC OXIDE DONORS; NITROSATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 33846821822     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2007.05660.x     Document Type: Review

References (107)

1. Jones SP & Bolli R (2006) The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40, 16-23.
2. Elahi MM & Matata B (2006) Free radicals in blood: evolving concepts in the mechanism of ischemic heart disease. Arch Biochem Biophys 450, 78-88.
3. Ischiropolous H (2003) Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun 305, 776-783.
4. Gow AJ, Farkouh CR, Munson DA, Posencheg MA & Ischiropoulos H (2004) Biological significance of nitric oxide-mediated protein modifications. Am J Physiol Lung Cell Mol Physiol 28, L262-L268.
5. Gladwin MT, Schechter AN, Kim-Shapiro DB, Patel RP, Hogg N, Shiva S, Cannon RO 3rd, Kelm M, Wink DA, Espey MG et al. (2005) The emerging biology of the nitrite anion. Nat Chem Biol 1, 308-314.
6. Naseem KM (2005) The role of nitric oxide in cardiovascular diseases. Mol Aspects Med 26, 33-65.
7. Elahi MM & Matata BM (2005) Blood-dependent redox activity during extracorporeal circulation in health and disease. Cardiology 1, 156-157.
8. Elahi MM, Courtney JM & Matata BM (2005) The interaction between reactive oxygen species and proinflammatory cytokines in human blood during extracorporeal circulation. Filtration 1, 89-94.
9. Elahi MM, Matata BM & Galinanes M (2004) Oxidant species are less effective in modulating proinflammatory cytokine turnover in ischaemic heart disease. J Mol Cell Cardiol 37, 245.
10. Matata BM & Elahi MM (2004) Peroxynitrite: an intriguing double-agent in biology and cardiovascular disease. In Recent Research Developments in Biophysics (Pandalai SG, ed.), Vol. 3, Part I, pp. 93-112. Gayathri, Kerala.
11. Elahi MM & Matata BM (2004) Nitric oxide modulates the inflammatory response to extracorporeal circulation of blood through activation of NF-kappa B. Circulation 101, 358.
12. Hess DT, Matsumoto A, Kim SO, Marshall H & Stamler JS (2004) Protein S-nitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6, 150-166.
13. Abu-Soud H, Rousseau DL & Stuehr DJ (2005) Nitric oxide binding to the heme of neuronal nitric-oxide synthase links its activity to changes in oxygen tension. J Biol Chem 271, 32515-32518.
14. Cesselli D, Jakoniuk I, Barlucchi L, Beltrami AP, Hintze TH, Nadal-Ginard B, Kajstura J, Leri A & Anversa P (2001) Oxidative stress-mediated cardiac cell death is a major determinant of ventricular dysfunction and failure in dog dilated cardiomyopathy. Circ Res 89, 279-286.
15. Siwik DA, Tzortzis JD, Pimental DR, Chang DL, Pagano PJ, Singh K, Sawyer DB & Colucci WS (1999) Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res 85, 147-153.
16. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr (1998) Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95, 9220-9225.
17. Gorren AC, Bec N, Schrammel A, Werner ER, Lange R & Mayer B (2000) Low-temperature optical absorption spectra suggest a redox role for tetrahydrobiopterin in both steps of nitric oxide synthase catalysis. Biochemistry 39, 11763-11770.
18. Pritchard KA Jr, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, Wolin MS & Stemerman MB (1995) Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 77, 510-518.
19. Laursen JB, Somers M, Kurz S, McCann L, Warnholtz A, Freeman BA, Tarpey M, Fukai T & Harrison DG (2001) Endothelial regulation of vasomotion in apo-Edeficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103, 1282-1288.
20. Cadenas E & Davies KJ (2000) Mitochondrial free radical generation, oxidative stress, and aging. Free Radical Biol Med 29, 222-230.
21. Ramachandran A, Levonen AL, Brookes PS, Ceaser E, Shiva S, Barone MC & Darley-Usmar V (2002) Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radical Biol Med 33, 1465-1474.
22. De Marchi U, Mancon M, Battaglia V, Ceccon S, Cardellini P & Toninello A (2004) Influence of reactive oxygen species production by monoamine oxidase activity on aluminum-induced mitochondrial permeability transition. Cell Mol Life Sci 61, 2664-2671.
23. Ishida I, Kubo H, Suzuki S, Suzuki T, Akashi S, Inoue K, Maeda S, Kikuchi H, Sasaki H & Kondo T (2002) Hypoxia diminishes toll-like receptor 4 expression through reactive oxygen species generated by mitochondria in endothelial cells. J Immunol 169, 2069-2075.
24. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C & Brownlee M (2001) Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108, 1341-1348.
25. Nishikawa T, Du Edelstein DXL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I et al. (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790.
26. Ballinger SW, Patterson C, Knight-Lozano CA, Burow DL, Conklin CA, Hu Z, Reuf J, Horaist C, Lebovitz R, Hunter GC et al. (2002) Mitochondrial integrity and function in atherogenesis. Circulation 106, 544-549.
27. Palacios-Callender M, Quintero M, Hollis VS, Springett RJ & Moncada S (2004) Endogenous NO regulates superoxide production at low oxygen concentrations by modifying the redox state of cytochrome c oxidase. Proc Natl Acad Sci USA 101, 7630-7635.
28. 2 in S-nitrosylation of the channel. J Biol Chem 278, 8184-8189.
29. Erwin PA, Lin AJ, Golan DE & Michel T (2005) Receptor-regulated dynamic S-nitrosylation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 280, 19888-19894.
30. Erwin PA, Mitchell DA, Sartoretto J, Marletta MA & Michel T (2006) Subcellular targeting and differential S-nitrosylation of endothelial nitric-oxide synthase. J Biol Chem 281, 151-157.
31. Liu L, Yan Y, Zeng M, Zhang J, Hanes MA, Ahearn G, McMahon TJ, Dickfeld T, Marshall HE, Que LG et al. (2004) Essential roles of S-nitrosothiols in vascular homeostasis and endotoxic shock. Cell 116, 617-628.
32. Low SY, Sabetkar M, Bruckdorfer KR & Naseem KM (2002) The role of protein nitration in the inhibition of platelet activation by peroxynitrite. FEBS Lett 511, 59-64.
33. Stamler JS, Lamas S & Fang FC (2001) Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106, 675-683.
34. Forman HJ, Fukuto JM & Torres M (2004) Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am J Physiol Cell Physiol 287, 246-256.
35. Stamler JS & Hausladen A (1998) Oxidative modifications in nitrosative stress. Nat Struct Biol 5, 247-249.
36. Kwon J, Lee SR, Yang KS, Ahn Y, Kim YJ, Stadtman ER & Rhee SG (2004) Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors. Proc Natl Acad Sci USA 101, 16419-16424.
37. Schechter AN & Gladwin MT (2003) Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med 348, 1483-1485.
38. McMahon TJ, Moon RE, Luschinger BP, Carraway MS, Stone AE, Stolp BW, Gow AJ, Pawloski JR, Watke P, Singel DJ et al. (2002) Nitric oxide in the human respiratory cycle. Nat Med 8, 711-717.
39. Furchgott RF & Bhadrakom S (1953) Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther 108, 129-143.
40. Gladwin MT, Shelhamer JH, Schechter AN, Pease-Fye ME, Waclawiw MA, Panza JA, Ognibene FP & Cannon RO 3rd (2000) Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci USA 97, 11482-11487.
41. Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang JD Jr, Kraus D et al. (2006) Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood 107, 566-574.
42. Adam JM, Ettelaie C, Naseem KM, James NJ, Bradley NJ & Bruckdorfer KR (1998) Modification of tissue factor by peroxynitrite influences its procoagulant activity. FEBS Lett 429, 347-350.
43. Crawford JH, White CR & Patel RP (2003) Vasoactivity of S-nitrosohemoglobin: role of oxygen, heme, and NO oxidation states. Blood 101, 4408-4415.
44. Suzuki YJ, Forman HJ & Sevanian A (1997) Oxidants as stimulators of signal transduction. Free Radical Biol Med 22, 269-285.
45. Grover AK, Samson SE & Fomin VP (1992) Peroxide inactivates calcium pumps in pig coronary artery. Am J Physiol 263, 537-543.
46. Doan TN, Gentry DL, Taylor AA & Elliott SJ (1994) Hydrogen peroxide activates agonist-sensitive Ca(2+)-flux pathways in canine venous endothelial cells. Biochem J 297, 209-215.
47. Sundaresan M, Yu ZX, Ferrans VJ, Irani K & Finkel T (1995) Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296-299.
48. Sabetkar M, Naseem KM, Tullett JM, Friebe A, Koesling D & Bruckdorfer KR (2001) Synergism between nitric oxide and hydrogen peroxide in the inhibition of platelet function: the roles of soluble guanylyl cyclase and vasodilator-stimulated phosphoprotein. Nitric Oxide 5, 233-242.
49. Kunsch C & Medford RM (1999) Oxidative stress as a regulator of gene expression in the vasculature. Circ Res 85, 753-766.
50. 2- in vascular smooth muscle cells. Circ Res 77, 29-36.
51. Rubbo H & O'Donnell V (2005) Nitric oxide, peroxynitrite and lipoxygenase in atherogensis: mechanistic insights. Toxicology 208, 305-317.
52. Ushio-Fukai M, Alexander RW, Akers M & Griendling KK (1998) p38 mitogen-activated protein kinase is a critical component of the redox-sensitive signaling pathways activated by angiotensin II: role in vascular smooth muscle cell hypertrophy. J Biol Chem 273, 15022-15029.
53. Bhunia AK, Han H, Snowden A & Chatterjee S (1997) Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem 272, 15642-15649.
54. Hout J, Houle F, Marceau F & Landry J (1997) Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells. Circ Res 80, 383-392.
55. Bapat S, Verkleij A & Post JA (2001) Peroxynitrite activates mitogen-activated protein kinase (MAPK) via a MEK-independent pathway: a role for protein kinase C. FEBS Lett 499, 21-26.
56. Winyard PG & Blake DR (1997) Antioxidants, redox-regulated transcription factors, and inflammation. Adv Pharmacol 38, 403-421.
57. Wung BS, Cheng JJ, Hsieh HJ, Shyy YJ & Wang DL (1997) Cyclic strain-induced monocyte chemotactic protein-1 gene expression in endothelial cells involves reactive oxygen species activation of activator protein 1. Circ Res 81, 1-7.
58. Rao GN, Lassegue B, Griendling KK, Alexander RW & Berk BC (1993) Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: role of protein kinase C. Nucleic Acids Res 21, 1259-1263.
59. Rao GN, Lassegue B, Griendling KK & Alexander RW (1993) Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: role of arachidonic acid. Oncogene 8, 2759-2764.
60. Del Arco PG, Martinez-Martinez S, Calvo V, Armesilla AL & Redondo JM (1997) Antioxidants and AP-1 activation: a brief overview. Immunobiology 198, 273-278.
61. Winyard PG, Moody CJ & Jacob C (2005) Oxidative activation of antioxidant defence. Trends Biochem Sci 30, 453-461.
62. Ellis L, Gilston V, Soo CC, Morris CJ, Kidd BL & Winyard PG (2000) Activation of the transcription factor NF-kappa B in the rat air pouch model of inflammation. Ann Rheum Dis 59, 303-307.
63. Maruyama I, Shigeta K, Miyahara H, Nakajima T, Shin H, Ide S & Kitajima I (1997) Thrombin activates NF-kappa B through thrombin receptor and results in proliferation of vascular smooth muscle cells: role of thrombin in atherosclerosis and restenosis. Ann NY Acad Sci 811, 429-436.
64. Brand K, Page S, Walli AK, Neumeier D & Baeuerle PA (1997) Role of nuclear factor-B in atherogenesis. Exp Physiol 82, 297-304.
65. Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA & Neumeier D (1996) Activated transcription factor NFB is present in the atherosclerotic lesion. J Clin Invest 97, 1715-1722.
66. Liao F, Andalibi A, deBeer FC, Fogelman AM & Susis AJ (1993) Genetic control of inflammatory gene induction and NF-B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 91, 2572-2579.
67. Yan SD, Schmidt AM, Andrson GM, Zhang J, Brett J, Zou YS, Pinsky D & Stern D (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269, 9889-9897.
68. Suzuki YJ, Miauno M & Packer L (1994) Signal transduction for NF-B activation: proposed location of antioxidant-inhibitable step. J Immunol 153, 5008-5015.
69. Suzuki YJ & Packer L (1993) Inhibition of NF-B activation by vitamin E derivatives. Biochem Biophys Res Commun 193, 227-283.
70. Hattori Y, Kasai K & Gross SS (2004) NO suppresses while peroxynitrite sustains NF-kappaB: a paradigm to rationalize cytoprotective and cytotoxic actions attributed to NO. Cardiovasc Res 63, 31-40.
71. Bar-Shai M & Reznick AZ (2006) Reactive nitrogen species induce nuclear factor-kappaB-mediated protein degradation in skeletal muscle cells. Free Radical Biol Med 15, 2112-2125.
72. Hayashi T, Ueno Y & Okamoto T (1993) Oxidoreductive regulation of nuclear factor kappa B: involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 268, 11380-11388.
73. Schreck R, Rieber P & Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-B transcription factor and HIV-1. EMBO J 10, 2247-2225.
74. Jiang C, Ting AT & Seed B (1998) PPAR-agonists inhibit production of monocyte inflammatory cytokines. Nature 391, 82-86.
75. Marx N, Borucier T, Sukhova GK & Plutzky J (1998) Human endothelial cells contain PPARs: evidence for PPAR in atheroma and its regulation of PAI-1 expression. Circulation 98, 383.
76. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC et al. (1998) Activation of human aortic smooth muscle cells is inhibited by PPAR but not by PPAR activators. Nature 393, 790-793.
77. Tontonoz P, Nagy L, Alvarez JGA, Thomazy VA & Evans RM (1988) PPAR promotes monocyte/macrophage activation and uptake of oxidized LDL. Cell 93, 241-252.
78. Godber BL, Doel JJ, Sapkota GP, Blake DR, Stevens CR, Eisenthal R & Harrison R (2000) Reduction of organic nitrites to nitric oxide catalyzed by xanthine oxidase: possible role in metabolism of nitrovasodilators. Biochem Biophys Res Commun 270, 880-885.
79. Li H, Samouilov A, Liu X & Zweier JL (2001) Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide generation in anoxic tissues. J Biol Chem 276, 24482-24489.
80. Nagy L, Tontonoz P, Alvarez JGA, Chen H & Evans RM (1998) Oxidized LDL regulates macrophage gene expression through ligand activation of PPAR. Cell 93, 229-240.
81. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marban E & Hare JM (2001) Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation 104, 2407-2411.
82. Heymes C, Bendall JK, Ratajczak P, Cave AC, Samuel JL, Hasenfuss G & Shah AM (2003) Increased myocardial NADPH oxidase activity in human heart failure. J Am Coll Cardiol 41, 2164-2171.
83. 2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 280, H2649-H2657.
84. Maytin M, Siwik DA, Ito M, Xiao L, Sawyer DB, Liao R & Colucci WS (2004) Pressure overload-induced myocardial hypertrophy in mice does not require gp91 (phox). Circulation 109, 1168-1171.
85. Cote CG, Yu FS, Zulueta JJ, Vosatka RJ & Hassoun PM (1996) Regulation of intracellular xanthine oxidase by endothelial-derived nitric oxide. Am J Physiol Lung Cell Mol Physiol 15, 869-874.
86. Shinyashiki M, Pan CJG, Lopez BE & Fukuto JM (2004) Inhibition of the yeast metal reductase heme protein Fre1 by nitric oxide (NO): a model for inhibition of NADPH oxidase by NO. Free Radical Biol Med 37, 713-723.
87. Hare JM (2003) Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol 35, 719-729.
88. Xu L, Eu JP, Meissner G & Stamler JS (1998) Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279, 234-237.
89. Lipton AJ, Johnson MA, Macdonald T, Lieberman MW, Gozal D & Gaston B (2001) S-nitrosothiols signal the ventilatory response to hypoxia. Nature 413, 171-174.
90. Mollnau H, Wendt M, Szocs K, Lassegue B, Schulz E, Oelze M, Li H, Bodenschatz M, August M, Kleschyov AL et al. (2002) Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling. Circ Res 90, 58-65.
91. Singel DJ & Stamler JS (2005) Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S- nitrosohemoglobin. Annu Rev Physiol 67, 99-145.
92. Foster MW, McMahon TJ & Stamler JS (2003) S-nitrosylation in health and disease. Trends Mol Med 9, 160-168.
93. Datta B, Tufnell-Barrett T, Bleasdale RA, Jones CJ, Beeton I, Paul V, Frenneaux M & James P (2004) Red blood cell nitric oxide as an endocrine vasoregulator - a potential role in congestive heart failure. Circulation 109, 1339-1342.
94. Huang KT, Han TH, Hyduke DR, Vaughn MW, Van Herle H, Hein TW, Zhang C, Kuo L & Liao JC (2001) Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci USA 98, 11771-11776.
95. Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO, Schechter AN & Gladwin MT (2002) Cellfree hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 8, 1383-1389.
96. Olson JS, Foley EW, Rogge C, Tsai AL, Doyle MP & Lemon DD (2004) No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radical Biol Med 36, 685-697.
97. 2/NO-linked allosteric function. J Biol Chem 277, 27818-27828.
98. Cosby K, Partovi KS, Crawford JH, Patel RP, Reiter CD, Martyr S, Yang BK, Waclawiw MA, Zalos G, Xu X et al. (2003) Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med 9, 1498-1505.
99. Patel RP, Hogg N, Spencer NY, Kalyanaraman B, Matalon S & Darley-Usmar VM (1999) Biochemical characterization of human S-nitrosohemoglobin: effects on oxygen binding and transnitrosation. J Biol Chem 274, 15487-15492.
100. Elahi MM & Matata BM (2006) The paradox of exogenous versus endogenous nitric oxide: modulation of blood pro and anti-inflammatory mechanisms. Filtration in press.
101. Pawloski JR (2003) Hemoglobin and nitric oxide. N Engl J Med 349, 402-405.
102. Bryan NS, Rassaf T, Maloney RE, Rodriguez CM, Saijo F, Rodriguez JR & Feelisch M (2004) Cellular targets and mechanisms of nitros(yl)ation: an insight into their nature and kinetics in vivo. Proc Natl Acad Sci USA 101, 4308-4313.
103. Paolocci N, Ekelund UE, Isoda T, Ozaki M, Vandegaer K, Georgakopoulos D, Harrison RW, Kass DA & Hare JM (2000) cGMP-independent inotropic effect of nitric oxide and peroxynitrite donors: potential role for S- nitrosylation. Am J Physiol 279, 1982-1988.
104. Sun J, Xin C, Eu JP, Stamler JS & Meissner G (2001) Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci USA 98, 11158-11162.
105. Khan SA, Lee K, Minhas KM, Gonzalez DR, Raju SV, Tejani AD, Li D, Berkowitz DE & Hare JM (2004) Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci USA 101, 15944-15948.
106. Damy T, Ratajczak P, Robidel E, Bendall JK, Oliviero P, Boczkowski J, Ebrahimian T, Marotte F, Samuel JL & Heymes C (2003) Up-regulation of cardiac nitric oxide synthase 1-derived nitric oxide after myocardial infarction in senescent rats. FASEB J 17, 1934-1936.
107. Damy T, Ratajczak P, Shah AM, Camors E, Marty I, Hasenfuss G, Marotte F, Samuel JL & Heymes C (2004) Increased neuronal nitric oxide synthase-derived NO production in the failing human heart. Lancet 363, 1365-1367.